HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA

Clinical trials for HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA trials appear

Sign up with your email to follow new studies for HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope drug enters first human tests for dozens of tough cancers

Disease control Ongoing

This is an early-stage study to find a safe dose of a new drug called KFA115, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced cancers that have stopped responding to standard treatments. The main goal is to check for side effects and determ…

Matched conditions: HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA

Get alerted when new HIGH MICROSATELLITE INSTABILITY COLORECTAL CARCINOMA trials appear

New hope drug enters first human tests for dozens of tough cancers